Felipe Duran
CIK 1964267 · View on SEC EDGAR ↗
First SEC filing: Feb. 14, 2023 · Latest: Feb. 14, 2023
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| March 19, 2026 | IBIO | P | 24,835 | $2.02 | $50,167 | 35,974 Direct | +222.96% | Acquired | -28.2% (price as of 2026-08-20) |
| Jan. 10, 2025 | IBIO | P | 9,191 | $2.72 | $25,000 | 11,139 Direct | +471.82% | Acquired | -46.7% (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Jan. 28, 2026 | IBIO | Stock Option (right to buy) [F1] | Common Stock (179,000) | $2.23 | Jan. 27, 2036 | 179,000 | Acquired |
| Oct. 20, 2025 | IBIO | Stock Option (right to buy) [F1] | Common Stock (75,000) | $0.89 | Oct. 19, 2035 | 75,000 | Acquired |
| Feb. 21, 2025 | IBIO | Stock Option (right to buy) [F1] | Common Stock (84,700) | $3.48 | Feb. 20, 2035 | 84,700 | Acquired |
| May 9, 2024 | IBIO | Stock Option (right to buy) [F1] | Common Stock (90,000) | $1.88 | May 9, 2034 | 90,000 | Acquired |
| April 25, 2024 | IBIO | Stock Option (right to buy) [F1] | Common Stock (35,800) | $1.72 | April 25, 2034 | 35,800 | Acquired |
| Aug. 23, 2023 | IBIO | Stock Option (right to buy) [F1] | Common Stock (60,000) | $0.35 | Aug. 23, 2033 | 60,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 4 holdings
Securities held when first becoming an insider, per SEC Form 3.